Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome - Top-Institutions - MDSpire

Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome

  • By

  • Maria A. Gascon

  • Vicente Aguilella

  • Tomas Martinez

  • Luigi Antinolfi

  • Javier Valencia

  • Jose M. Ramírez

  • June 22, 2022

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Colorectal Surgery
    • Surgical Oncology
    • Gastroenterology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Colorectal Surgery
    • Radiation Oncology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Colorectal Surgery
    • Gastroenterology
    • Oncology

  • #4

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Colorectal Surgery
    • Surgical Oncology
    • Gastroenterology

  • #5

    St. Mark’s Hospital
    St. Mark’s Hospital

    London, England

    Key Differentiators

    • Colorectal Surgery
    • Gastroenterology
    • Oncology

Original Source(s)

Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome

  • by Maria A. Gascon, Vicente Aguilella, Tomas Martinez, Luigi Antinolfi, Javier Valencia, Jose M. Ramírez

  • June 22, 2022

Related Content

A volume-controlled, anatomy-driven autoplanning strategy for whole-pelvic volumetric modulated arc therapy

Dosimetric Evaluation of IMRT and VMAT Techniques with Deep Inspiration Breath Hold versus Free Breathing for Whole Breast Irradiation on the Right Side

Dose Estimation Using 3D Transformer Models in High-Dose-Rate Brachytherapy for Cervical Cancer